Jan Portegys

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Systemic Sclerosis

Peripheral Blood

Top Venues

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Portegys, Anke Heidemeier, Andreas Rosenwald, Michael Gernert, Matthias Fröhlich, Sebastian Hueper, Patrick Pascal Strunz, Leo Rasche, Marc Schmalzing
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib. RMD open 9 (1) (2023)
Jan Portegys, Anke Heidemeier, Andreas Rosenwald, Michael Gernert, Matthias Fröhlich, Sebastian Hueper, Patrick Pascal Strunz, Leo Rasche, Marc Schmalzing
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib. RMD open 9 (1) (2023)
Jan Portegys, Anke Heidemeier, Andreas Rosenwald, Michael Gernert, Matthias Fröhlich, Sebastian Hueper, Patrick Pascal Strunz, Leo Rasche, Marc Schmalzing
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib. RMD open 9 (1) (2023)
Jan Portegys, Anke Heidemeier, Andreas Rosenwald, Michael Gernert, Matthias Fröhlich, Sebastian Hueper, Patrick Pascal Strunz, Leo Rasche, Marc Schmalzing
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib. RMD open 9 (1) (2023)
Michael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, Ottar Gadeholt, Matthias Fröhlich, Jan Portegys, Patrick-Pascal Strunz, Schmalzing Marc
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication. Rheumatology international (2021)